Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bioavailability of Orally Administered Active Lipid Compounds from four Different Greenshell™ Mussel Formats.
Mar Drugs. 2020 Oct 23;18(11):524. doi: 10.3390/md18110524.
Mar Drugs. 2020.
PMID: 33114125
Free PMC article.
Clinical Trial.
Comparative pharmacokinetics of subcutaneous trastuzumab administered via handheld syringe or proprietary single-use injection device in healthy males.
Wynne CJ, Ellis-Pegler RB, Waaka DS, Schwabe C, Lehle M, Heinzmann D, Mangat R, Li C, Dick AE, Cranshaw NA, Lum BL.
Wynne CJ, et al. Among authors: waaka ds.
Cancer Chemother Pharmacol. 2013 Nov;72(5):1079-87. doi: 10.1007/s00280-013-2273-z. Epub 2013 Sep 22.
Cancer Chemother Pharmacol. 2013.
PMID: 24057039
Clinical Trial.
Item in Clipboard
Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer.
Wynne C, Harvey V, Schwabe C, Waaka D, McIntyre C, Bittner B.
Wynne C, et al. Among authors: waaka d.
J Clin Pharmacol. 2013 Feb;53(2):192-201. doi: 10.1177/0091270012436560.
J Clin Pharmacol. 2013.
PMID: 23436264
Clinical Trial.
Item in Clipboard
Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer.
Wynne C, Harvey V, Schwabe C, Waaka D, McIntyre C, Bittner B.
Wynne C, et al. Among authors: waaka d.
J Clin Pharmacol. 2013 Jan 24. doi: 10.1177/0091270011436560. Online ahead of print.
J Clin Pharmacol. 2013.
PMID: 23504807
Item in Clipboard
Reply to: letter to the editor "subcutaneous herceptin therapy".
Wynne C, Harvey V, Schwabe C, Waaka D, McIntyre C, Bittner B.
Wynne C, et al. Among authors: waaka d.
J Clin Pharmacol. 2013 Dec;53(12):1343-4. doi: 10.1002/jcph.172. Epub 2013 Sep 21.
J Clin Pharmacol. 2013.
PMID: 23996383
No abstract available.
Item in Clipboard
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
Gruppo RA, Malan D, Kapocsi J, Nemes L, Hay CRM, Boggio L, Chowdary P, Tagariello G, von Drygalski A, Hua F, Scaramozza M, Arkin S; Marzeptacog alfa (activated) Study Group Investigators.
Gruppo RA, et al.
J Thromb Haemost. 2018 Oct;16(10):1984-1993. doi: 10.1111/jth.14247. Epub 2018 Aug 27.
J Thromb Haemost. 2018.
PMID: 30151972
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite